Back
Cabaletta Bio Vs. Eloxx Pharmaceuticals Industry Stock Comparison
Sell
23
CABA
Cabaletta Bio
Last Price:
11.98
Seasonality Move:
32.98%
Sell
12
ELOX
Eloxx Pharmaceuticals
Last Price:
0.81
Seasonality Move:
4.29%
Sell
23
Cabaletta Bio (CABA)
is a Sell
Is Cabaletta Bio a Buy, Sell or Hold?
- The current Cabaletta Bio [CABA] share price is $12.96. The Score for CABA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- CABA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
12
Eloxx Pharmaceuticals (ELOX)
is a Sell
Is Eloxx Pharmaceuticals a Buy, Sell or Hold?
- The current Eloxx Pharmaceuticals [ELOX] share price is $0.81. The Score for ELOX is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
- ELOX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CABA Stock Price Chart
What is Cabaletta Bio's stock price today?
-
The Cabaletta Bio share price today is $12.96
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CABA is experiencing selling pressure, which indicates risk of future bearish movement.
ELOX Stock Price Chart
What is Eloxx Pharmaceuticals's stock price today?
-
The Eloxx Pharmaceuticals share price today is $0.81
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ELOX is experiencing slight selling pressure.
CABA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.55 | Sell |
| Relative Strength Index (14 RSI): | 24.21 | Sell |
| Chaikin Money Flow: | -642185 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.67 - 17.97) | Sell |
| Bollinger Bands (100): | (16.91 - 23.15) | Sell |
ELOX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 37.77 | Sell |
| Chaikin Money Flow: | -625 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.88 - 1.04) | Sell |
| Bollinger Bands (100): | (0.8 - 1.08) | Sell |
CABA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.31 | Sell |
| 20-day SMA: | 16.06 | Sell |
| 50-day SMA: | 19.1 | Sell |
| 200-day SMA: | 17.27 | Sell |
| 8-day EMA: | 14.23 | Sell |
| 20-day EMA: | 15.82 | Sell |
| 50-day EMA: | 17.91 | Sell |
| 200-day EMA: | 17.03 | Sell |
ELOX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.89 | Sell |
| 20-day SMA: | 0.96 | Sell |
| 50-day SMA: | 0.92 | Sell |
| 200-day SMA: | 2.58 | Sell |
| 8-day EMA: | 0.87 | Sell |
| 20-day EMA: | 0.93 | Sell |
| 50-day EMA: | 0.96 | Sell |
| 200-day EMA: | 2.46 | Sell |
Cabaletta Bio Earnings Growth & CABA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.28 per share, and a decrease next year of $0.07 per share.
Eloxx Pharmaceuticals Earnings Growth & ELOX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.35 per share, and an increase next year of $0.61 per share.
Cabaletta Bio Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Eloxx Pharmaceuticals Technical Analysis
| Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||